DirectMeds makes two claims that stand out in this market, and both deserve scrutiny rather than applause. Claim one: plans start at $249/month for sublingual semaglutide and $297/month for injections, with no subscriptions. Claim two: you can take it as weekly injections or as needle-free sublingual drops. The first claim is simple economics; the second is unusual medicine. Let's check both.
The economics first: the page does not tie the $297 injection price to a named medication, so we list no tirzepatide price, and it does not say whether the price changes with dose. It also offers 6- and 12-month bulk plans without pricing them. Before November 18, 2026 the page showed a different, flat price; that figure is no longer there.



